user

Real -World Safety and tolerability of Elexacaftor/Tezacaftor/ Ivacaftor in the treatment of Cystic Fibrosis: A single centre experience

被引：0
|
作者：
Casey, Michelle [1 ,2 ]
Gabillard-Lefort, Claudie [1 ]
Kerr, Orla [2 ]
Marron, Elaine [2 ]
Lyons, Anne-Marie [2 ]
Reddy, Ciara [2 ]
Gunaratnam, Cedric [1 ,2 ]
Reeves, Emer P. [1 ]
McElvaney, Noel G. [1 ,2 ]
机构：
[1] Royal Coll Surgeons Ireland, Dept Med, Irish Ctr Genet Lung Dis, Dublin, Ireland
[2] Beaumont Hosp, Dept Resp Med, Cyst Fibrosis Unit, Dublin, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2021年 / 190卷 / SUPPL 5期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4.7
引用
收藏
页码：180 / 181
页数：2
相关论文
共 50 条
  • [1] Safety and effectiveness of treatment with elexacaftor, tezacaftor and ivacaftor in adults with cystic fibrosis
    Royo, Rosa Nieto
    Barata, Diego Duran
    Barreto, Deisy Barrios
    Franquiz, Winnifer Briceno
    Carro, Luis Maiz
    [J]. MEDICINA CLINICA, 2023, 161 (08): : 338 - 341
  • [2] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [3] Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
    Hernandez, Laura Carrasco
    Moreno, Rosa Ma Giron
    Cartagena, Mari Nieves Balaguer
    Pelaez, Adrian
    Sole, Amparo
    Fernandez, Antonio Alvarez
    Montiel, Almudena Felipe
    Olveira, Casilda
    Olveira, Gabriel
    Bonilla, Ainhoa Gomez
    Crespo, Beatriz Gomez
    Clemente, Marta Garcia
    Garcia, Marta Solis
    Vazquez, Joana Quaresma
    Castro, Enrique Blitz
    Gonzalez, Jesus Rodriguez
    Marrero, Andrea Exposito
    Diab-Caceres, Laila
    Hernandez, Cristina Ramos
    de Lucas, Ester Zamarron
    Sanchez, Concha Prados
    Aparicio, Marina Blanco
    Neyra, Alejandro Lopez
    Santiago, Veronica Sanz
    Paredes, Carmen Luna
    Pecellin, Isabel Delgado
    de la Cruz, Oscar Asensio
    Gallego, Esther Quintana
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (09): : 556 - 565
  • [4] ELEXACAFTOR/TEZACAFTOR/IVACAFTOR CLINICAL EXPERIENCE IN ADULT CYSTIC FIBROSIS PATIENTS
    Finke, J. H.
    Indihar, M.
    Khawar, M.
    Kopras, E.
    Galloway, J.
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 : S226 - S226
  • [5] Efficacy and Safety of Elexacaftor-Tezacaftor-Ivacaftor in the Treatment of Cystic Fibrosis: A Systematic Review
    Kapouni, Nikoletta
    Moustaki, Maria
    Douros, Konstantinos
    Loukou, Ioanna
    [J]. CHILDREN-BASEL, 2023, 10 (03):
  • [6] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    [J]. PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
  • [7] Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis
    De Vuyst, Richard C.
    Bennard, Erin
    Kam, Charissa W.
    McKinzie, Cameron J.
    Esther, Charles R.
    [J]. PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1592 - 1594
  • [8] SINGLE-CENTER EXPERIENCE OF PEDIATRIC CYSTIC FIBROSIS PATIENTS STARTED ON ELEXACAFTOR/TEZACAFTOR/IVACAFTOR
    Allan, K.
    Carr, P.
    Denhard, M.
    Mogayzel, P. J.
    Pan, A.
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 : S224 - S224
  • [9] Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on liver tests at a large single adult cystic fibrosis centre
    Tewkesbury, Daniel H.
    Athwal, Varinder
    Bright-Thomas, Rowland J.
    Jones, Andrew M.
    Barry, Peter J.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (02) : 256 - 262
  • [10] Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis
    Lonabaugh, Kevin
    Li, Galvin
    List, Rhonda
    Huang, Reyna
    James, Amber
    Barros, Andrew
    Somerville, Lindsay
    Albon, Dana
    [J]. PHARMACOTHERAPY, 2024, 44 (03): : 231 - 240
12345